Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/jc.2009-2170PMID 19915015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.

  2009cited by this paper
• IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors

  2009cited by this paper
• SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma

  2009cited by this paper
• Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

  2009cited by this paper
• An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.

  2009cited by this paper
• The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas

  2009cited by this paper
• Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

  2009cited by this paper
• The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.

  2009cited by this paper
• Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

  2009cited by this paper
• Recurring mutations found by sequencing an acute myeloid leukemia genome.

  2009cited by this paper
• Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome

  2009cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• Somatic SDHB mutation in an extraadrenal pheochromocytoma.

  2007cited by this paper
• Genetic Analyses of Apparently Sporadic Pheochromocytomas

  2006cited by this paper
• Expression of HIF-1α, HIF-2α (EPAS1), and Their Target Genes in Paraganglioma and Pheochromocytoma with VHL and SDH Mutations

  2006cited by this paper
• Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer

  2006cited by this paper
• Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.

  2006cited by this paper
• Genetic testing in pheochromocytoma or functional paraganglioma.

  2005cited by this paper
• Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.

  2005cited by this paper
• Germ-line mutations in nonsyndromic pheochromocytoma.

  2002cited by this paper
• VHL takes HIF’s breath away

  2000cited by this paper

• The genetics of hypertension

  2025cites this paper
• Deciphering the Multifaceted Roles and Clinical Implications of 2-Hydroxyglutarate in Cancer.

  2024cites this paper
• Management and follow-up strategies for patients with head and neck paraganglioma.

  2024cites this paper
• Recent progress in molecular classification of phaeochromocytoma and paraganglioma.

  2024cites this paper
• Patient Sex and Origin Influence Distribution of Driver Genes and Clinical Presentation of Paraganglioma

  2024cites this paper
• Mutant IDH in Gliomas: Role in Cancer and Treatment Options

  2023cites this paper
• Tumour microenvironment in pheochromocytoma and paraganglioma

  2023cites this paper
• The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma

  2023cites this paper
• Atypical cartilage in type II germ cell tumors of the mediastinum show significantly different patterns of IDH1/2 mutations from conventional chondrosarcoma

  2022cites this paper
• Advances in Adrenal and Extra-adrenal Paraganglioma: Practical Synopsis for Pathologists.

  2022cites this paper
• Somatic IDH1 hotspot variants in Chinese patients with pheochromocytomas and paragangliomas.

  2022cites this paper
• Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach

  2022cites this paper
• SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism.

  2022cites this paper
• Management of Pheochromocytomas and Paragangliomas: A Case-Based Review of Clinical Aspects and Perspectives

  2022cites this paper
• Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas

  2021cites this paper
• Pheochromocytoma and Paraganglioma

  2021cites this paper
• Isocitrate dehydrogenase gene variants in cancer and their clinical significance

  2021cites this paper
• Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations

  2021cites this paper
• Histopathology of Parasellar Neoplasms

  2020cites this paper
• Immunohistochemistry and Mutation Analysis of SDHx Genes in Carotid Paragangliomas

  2020cites this paper
• University of Birmingham Histopathology of parasellar neoplasms

  2020cites this paper
• Pheochromocytoma and Paraganglioma.

  2019cites this paper
• Understanding the Role of IDH Mutation in Chondrosarcoma

  2019cites this paper
• Novel potential causative genes in carotid paragangliomas

  2019cites this paper
• Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration

  2019cites this paper
• Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches

  2019cites this paper
• A systematic review on the genetic analysis of paragangliomas: primarily focused on head and neck paragangliomas.

  2019cites this paper
• Metabolomics in the Diagnosis of Pheochromocytoma and Paraganglioma

  2019cites this paper
• Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of Origin

  2019influential citation
• Pheochromocytomas in Complex Genetic Disorders

  2019cites this paper
• 2-Hydroxyglutarate in Cancer Cells

  2019cites this paper
• Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma

  2018cites this paper
• Pheochromocytomas, Paragangliomas and Disorders of the Sympathoadrenal System

  2018cites this paper
• Role des microARNs dans le controle de la voie de la sécrétion régulée dans les phéochromocytomes

  2018cites this paper
• Exome analysis of carotid body tumor

  2018cites this paper
• Chapter 3 Pheochromocytomas and Paragangliomas : A Focus on Genetics

  2018cites this paper
• The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes

  2018cites this paper
• Boosting support vector machines for cancer discrimination tasks

  2018cites this paper
• Biological Role and Therapeutic Potential of IDH Mutations in Cancer.

  2018cites this paper
• Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients

  2018cites this paper
• Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations

  2018cites this paper
• Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism

  2018cites this paper
• IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53

  2018cites this paper
• Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas

  2017influential citation
• Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma

  2017cites this paper
• Genetics of Pheochromocytomas and Paragangliomas: An Overview on the Recently Implicated Genes MERTK, MET, Fibroblast Growth Factor Receptor 1, and H3F3A.

  2017cites this paper
• Identification of diagnostic, prognostic and new major and minor susceptibility genes to pheochromacytoma amd paragangliomas (PCC/PGL)

  2017cites this paper
• Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.

  2017cites this paper
• Routine genetic screening with a multi-gene panel in patients with pheochromocytomas

  2017cites this paper
• Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas

  2017cites this paper
• Pheochromocytomas and Paragangliomas: A Focus on Genetics

  2017cites this paper
• PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.

  2017cites this paper
• Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer–Predisposing Mutations in Pheochromocytomas and Paragangliomas

  2017influential citation
• Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight

  2017cites this paper
• Molecular markers of paragangliomas/pheochromocytomas

  2017cites this paper
• Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy

  2017cites this paper
• 2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter.

  2017cites this paper
• A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas

  2016cites this paper
• Molecular characterisation of renal cell carcinoma and related disorders

  2016cites this paper
• Different strategies in the biochemical diagnosis of pheochromocytoma

  2016cites this paper
• Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas The NGS in PPGL ( NGSnPPGL ) Study Group

  2016cites this paper
• Mitochondrial metabolic remodeling in response to genetic and environmental perturbations

  2016cites this paper
• A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors

  2016cites this paper
• Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era.

  2016cites this paper
• Pheochromocytoma: The First Metabolic Endocrine Cancer

  2016cites this paper
• GEP- NETS UPDATE: Genetics of neuroendocrine tumors.

  2016cites this paper
• Recent Advances in the Genetics of Pheochromocytomas and Paragangliomas

  2016cites this paper
• University of Birmingham Mitochondrial metabolic remodelling in response to genetic and environmental perturbations

  2016cites this paper
• Genetics of neuroendocrine tumors

  2016cites this paper
• Somatic and germline mutations in NETs: Implications for their diagnosis and management.

  2016cites this paper
• Structural analysis of oncogenic mutation of isocitrate dehydrogenase 1.

  2016cites this paper
• The genomic landscape of phaeochromocytoma

  2015cites this paper
• Genetic Alterations in Pheochromocytoma and Paraganglioma

  2015cites this paper
• Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis

  2015cites this paper
• Genetic and molecular background of pheochromocytoma and paraganglioma

  2015cites this paper
• Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics.

  2015cites this paper
• Pheochromocytoma and paraganglioma.

  2015cites this paper
• TET proteins and the control of cytosine demethylation in cancer

  2015cites this paper
• 5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy.

  2015cites this paper
• Pheochromocytoma: Gasping for Air

  2015cites this paper
• The identification of new familial pheochromocytoma/paraganglioma genes using whole exome sequencing

  2015cites this paper
• Pathology of pheochromocytoma and paraganglioma

  2015cites this paper
• Isocitrate Dehydrogenase (IDH) Mutation in Gliomas

  2015cites this paper
• Paraganglioma and phaeochromocytoma: from genetics to personalized medicine

  2015cites this paper
• [Hereditary pheochromocytoma-associated syndromes. Part 2].

  2015cites this paper
• Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.

  2015cites this paper
• Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.

  2014cites this paper
• The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation.

  2014cites this paper
• HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors.

  2014cites this paper
• IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma

  2014cites this paper
• Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

  2014cites this paper
• Expression of IDH1 Mutant Protein R132H and SDHB in Adult and Pediatric Gliomas

  2014cites this paper
• Rare insights into cancer biology

  2014cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Clinical management of paragangliomas

  2014cites this paper
• Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

  2014influential citation
• Universal genetic screening uncovers a novel presentation of an SDHAF2 mutation.

  2014cites this paper
• Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity

  2014cites this paper
• Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.

  2014cites this paper
• Genetic Aspects of Endocrine Tumorigenesis : A Hunt for the Endocrine Neoplasia Gene

  2014cites this paper
• Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate.

  2014cites this paper